Oxybutynin Chloride
Product Images NDC 53217-335

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 53217-335). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aidarex Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Oxybutynin Chloride 5mg 1)

Chemical Structure (Oxybutynin Chloride 5mg 1)
Chemical structure diagram of the active ingredient in Oxybutynin Chloride, showing molecular bonds and functional groups including a cyclohexyl, phenyl, and ethylamine hydrochloride component.*
FDA Label Image

Figure 1 (Oxybutynin Chloride 5mg 2)

Figure 1 (Oxybutynin Chloride 5mg 2)
A pharmacokinetic graph showing the mean plasma R-Oxybutynin concentration (ng/mL) over 24 hours after administration of Oxybutynin 5 mg three times daily (TID). The x-axis represents time in hours, and the y-axis shows plasma concentration with error bars indicating variability.*
FDA Label Image

Figure 2 (Oxybutynin Chloride 5mg 3)

Figure 2 (Oxybutynin Chloride 5mg 3)
A line graph depicting mean R-Oxybutynin plasma concentration (ng/mL) over time (hours). The y-axis ranges from 0 to 10 ng/mL and the x-axis spans 0 to 12 hours. Data points show a peak concentration near 1 hour followed by a gradual decline to near baseline by 12 hours, with error bars indicating variability at each time point.*
FDA Label Image

53217-0335_oxybutynin-chloride_5mg (Oxybutynin Chloride 5mg 4)

53217-0335_oxybutynin-chloride_5mg (Oxybutynin Chloride 5mg 4)
Label for Oxybutynin Chloride USP 5 mg tablets by Aidarex Pharmaceuticals LLC, containing 30 white round tablets. The label includes generic reference to Ditropan, the NDC code 53217-0335-30, and manufacturer information for Upsher-Smith Laboratories, Inc. Dosage instructions and lot numbers are partially visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.